Cargando…
Evaluation of the Bleeding Intensity of Patients Anticoagulated with Warfarin or Dabigatran Undergoing Dental Procedures
BACKGROUND: Thrombotic disorders remain one of the leading causes of death in the Western world. Dabigatran appeared as an alternative to warfarin for anticoagulation in the treatment of atrial fibrillation (AF). The risk associated with bleeding due to its use has been documented in several randomi...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedade Brasileira de Cardiologia - SBC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6173350/ https://www.ncbi.nlm.nih.gov/pubmed/30088558 http://dx.doi.org/10.5935/abc.20180137 |
_version_ | 1783361109085913088 |
---|---|
author | Andrade, Marcus Vinicius Santos Andrade, Luciana Azevedo Prata Bispo, Alan Freitas Freitas, Luana de Alencar Andrade, Milena Quadros Sampaio Feitosa, Gilson Soares Feitosa-Filho, Gilson Soares |
author_facet | Andrade, Marcus Vinicius Santos Andrade, Luciana Azevedo Prata Bispo, Alan Freitas Freitas, Luana de Alencar Andrade, Milena Quadros Sampaio Feitosa, Gilson Soares Feitosa-Filho, Gilson Soares |
author_sort | Andrade, Marcus Vinicius Santos |
collection | PubMed |
description | BACKGROUND: Thrombotic disorders remain one of the leading causes of death in the Western world. Dabigatran appeared as an alternative to warfarin for anticoagulation in the treatment of atrial fibrillation (AF). The risk associated with bleeding due to its use has been documented in several randomized clinical trials, but no large study has examined in detail the risk of bleeding during dental extraction and other dental procedures involving bleeding. OBJECTIVE: To compare the intensity of bleeding in individuals taking dabigatran or vitamin K antagonist (warfarin) and undergoing dental procedures. METHODS: Prospective, single-center, controlled study with one single observer. Patients diagnosed with nonvalvular AF, on warfarin or dabigatran, cared for at a cardiology referral center, and requiring single or multiple dental extractions, were evaluated up to seven days post-extraction. The following outcomes were assessed: bleeding time between the beginning and the end of suture and complete hemostasis; bleeding before the procedure, after 24 hours, 48 hours, 7 days, during and after suture removal (late); p<0.05 was defined as of statistical relevance. RESULTS: We evaluated 37 individuals, 25 in the warfarin group and 12 in the dabigatran group. Age, sex, weight, height, blood pressure, color, schooling, family income and comorbidities were similar between the two groups. Regarding bleeding after 24 hours of the procedure, no one in the dabigatran group had bleeding, whereas 32% in the warfarin group had documented bleeding (p = 0.028). The other variables analyzed did not differ between the groups. CONCLUSIONS: This study suggests that, regarding dental extraction, there is no statistically significant difference in the intensity of bleeding of patients taking dabigatran as compared to those taking warfarin. Bleeding 24 hours after the procedure was less frequent among patients on dabigatran. |
format | Online Article Text |
id | pubmed-6173350 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Sociedade Brasileira de Cardiologia - SBC |
record_format | MEDLINE/PubMed |
spelling | pubmed-61733502018-10-10 Evaluation of the Bleeding Intensity of Patients Anticoagulated with Warfarin or Dabigatran Undergoing Dental Procedures Andrade, Marcus Vinicius Santos Andrade, Luciana Azevedo Prata Bispo, Alan Freitas Freitas, Luana de Alencar Andrade, Milena Quadros Sampaio Feitosa, Gilson Soares Feitosa-Filho, Gilson Soares Arq Bras Cardiol Original Article BACKGROUND: Thrombotic disorders remain one of the leading causes of death in the Western world. Dabigatran appeared as an alternative to warfarin for anticoagulation in the treatment of atrial fibrillation (AF). The risk associated with bleeding due to its use has been documented in several randomized clinical trials, but no large study has examined in detail the risk of bleeding during dental extraction and other dental procedures involving bleeding. OBJECTIVE: To compare the intensity of bleeding in individuals taking dabigatran or vitamin K antagonist (warfarin) and undergoing dental procedures. METHODS: Prospective, single-center, controlled study with one single observer. Patients diagnosed with nonvalvular AF, on warfarin or dabigatran, cared for at a cardiology referral center, and requiring single or multiple dental extractions, were evaluated up to seven days post-extraction. The following outcomes were assessed: bleeding time between the beginning and the end of suture and complete hemostasis; bleeding before the procedure, after 24 hours, 48 hours, 7 days, during and after suture removal (late); p<0.05 was defined as of statistical relevance. RESULTS: We evaluated 37 individuals, 25 in the warfarin group and 12 in the dabigatran group. Age, sex, weight, height, blood pressure, color, schooling, family income and comorbidities were similar between the two groups. Regarding bleeding after 24 hours of the procedure, no one in the dabigatran group had bleeding, whereas 32% in the warfarin group had documented bleeding (p = 0.028). The other variables analyzed did not differ between the groups. CONCLUSIONS: This study suggests that, regarding dental extraction, there is no statistically significant difference in the intensity of bleeding of patients taking dabigatran as compared to those taking warfarin. Bleeding 24 hours after the procedure was less frequent among patients on dabigatran. Sociedade Brasileira de Cardiologia - SBC 2018-09 /pmc/articles/PMC6173350/ /pubmed/30088558 http://dx.doi.org/10.5935/abc.20180137 Text en http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Andrade, Marcus Vinicius Santos Andrade, Luciana Azevedo Prata Bispo, Alan Freitas Freitas, Luana de Alencar Andrade, Milena Quadros Sampaio Feitosa, Gilson Soares Feitosa-Filho, Gilson Soares Evaluation of the Bleeding Intensity of Patients Anticoagulated with Warfarin or Dabigatran Undergoing Dental Procedures |
title | Evaluation of the Bleeding Intensity of Patients Anticoagulated with
Warfarin or Dabigatran Undergoing Dental Procedures |
title_full | Evaluation of the Bleeding Intensity of Patients Anticoagulated with
Warfarin or Dabigatran Undergoing Dental Procedures |
title_fullStr | Evaluation of the Bleeding Intensity of Patients Anticoagulated with
Warfarin or Dabigatran Undergoing Dental Procedures |
title_full_unstemmed | Evaluation of the Bleeding Intensity of Patients Anticoagulated with
Warfarin or Dabigatran Undergoing Dental Procedures |
title_short | Evaluation of the Bleeding Intensity of Patients Anticoagulated with
Warfarin or Dabigatran Undergoing Dental Procedures |
title_sort | evaluation of the bleeding intensity of patients anticoagulated with
warfarin or dabigatran undergoing dental procedures |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6173350/ https://www.ncbi.nlm.nih.gov/pubmed/30088558 http://dx.doi.org/10.5935/abc.20180137 |
work_keys_str_mv | AT andrademarcusviniciussantos evaluationofthebleedingintensityofpatientsanticoagulatedwithwarfarinordabigatranundergoingdentalprocedures AT andradelucianaazevedoprata evaluationofthebleedingintensityofpatientsanticoagulatedwithwarfarinordabigatranundergoingdentalprocedures AT bispoalanfreitas evaluationofthebleedingintensityofpatientsanticoagulatedwithwarfarinordabigatranundergoingdentalprocedures AT freitasluanadealencar evaluationofthebleedingintensityofpatientsanticoagulatedwithwarfarinordabigatranundergoingdentalprocedures AT andrademilenaquadrossampaio evaluationofthebleedingintensityofpatientsanticoagulatedwithwarfarinordabigatranundergoingdentalprocedures AT feitosagilsonsoares evaluationofthebleedingintensityofpatientsanticoagulatedwithwarfarinordabigatranundergoingdentalprocedures AT feitosafilhogilsonsoares evaluationofthebleedingintensityofpatientsanticoagulatedwithwarfarinordabigatranundergoingdentalprocedures |